title: HLA-DP in rheumatoid arthritis.
abstract: Frequencies of HLA-DR, Dw and DPw specificities were compared between rheumatoid arthritis (RA) patients, Felty's syndrome (FS) patients and normal controls. It was confirmed that the frequency of DR4 was increased in RA patients (54% (n = 111) vs 23% (n = 272), relative risk (RR) = 3.98, P less than 0.001). Cellular typing showed a highly significant increase in HLA-Dw14 in the entire RA population (17% (n = 32) vs 2% (n = 242), RR = 11.90, P less than 0.001), and a tendency towards an increase of HLA-Dw14 in DR4+ RA patients compared to DR4+ controls (28% (n = 32) vs 11% (n = 47), RR = 3.29, P less than 0.05). Regarding DPw specificities, the only significance was for a negative association with DPw3 (13% vs 22% (n = 254), RR = 0.51, P less than 0.05), with an additional tendential decrease of DPw1 (11% vs 19%, RR = 0.53, not significant (NS]. The decrease of DPw3 was more marked in DR4- RA patients (RR = 0.33, P less than 0.05) than in DR4+ RA patients (RR = 0.69, NS). In FS patients, 96% of whom were DR4+, decreased DPw1 was very marked, whereas the frequency of DPw3 was unaltered compared to DR4+ normals. These alterations in frequencies were not caused by linkage disequilibria between HLA-DR and -DP alleles. Thus, taken together, these data suggest that, in the presence of the major DR4-associated "susceptibility" gene(s) for RA, DPw1 may have "protective" effects, whereas in the absence of DR4, the presence of DPw3 has significant "protective" activity.
authors.affiliation: Immunology Laboratory, Medizinische Klinik, Tübingen, FRG.
authors.forename: G
authors.initials: G
authors.lastname: Pawelec
authors.forename: P
authors.initials: P
authors.lastname: Reekers
authors.forename: D
authors.initials: D
authors.lastname: Brackertz
authors.forename: D
authors.initials: D
authors.lastname: Sansom
authors.forename: E M
authors.initials: EM
authors.lastname: Schneider
authors.forename: M
authors.initials: M
authors.lastname: Blaurock
authors.forename: C
authors.initials: C
authors.lastname: Müller
authors.forename: A
authors.initials: A
authors.lastname: Rehbein
authors.forename: I
authors.initials: I
authors.lastname: Balko
authors.forename: P
authors.initials: P
authors.lastname: Wernet
mesh_terms: D001172:Arthritis, Rheumatoid / Q000235:genetics*; D005258:Felty Syndrome / Q000235:genetics; D005787:Gene Frequency; D008040:Genetic Linkage; D006681:HLA-D Antigens / Q000235:genetics*; D006682:HLA-DP Antigens / Q000235:genetics*; D059868:HLA-DP beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics; D015798:HLA-DR1 Antigen; D015804:HLA-DR4 Antigen; D006801:Humans
chemical_list: D006681:HLA-D Antigens; D006682:HLA-DP Antigens; D059868:HLA-DP beta-Chains; C055961:HLA-DPw3 antigen; D006684:HLA-DR Antigens; D015798:HLA-DR1 Antigen; D015804:HLA-DR4 Antigen; C050381:HLA-Dw14 antigen